Biotyx Medical (shenzhen) Co., Ltd.
Clinical trials sponsored by Biotyx Medical (shenzhen) Co., Ltd., explained in plain language.
-
Iron scaffold that melts away could change heart disease treatment
Disease control OngoingThis study tests a new device called an iron bioresorbable scaffold, which is placed in a blocked heart artery to keep it open and then slowly dissolves over time. It releases a drug to prevent re-blockage. The trial compares it to a standard permanent stent in about 518 adults w…
Phase: NA • Sponsor: Biotyx Medical (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Iron scaffold melts away after opening clogged arteries in heart disease trial
Disease control OngoingThis study tests a new device called the Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS) in 1059 people with coronary artery disease. The scaffold props open blocked heart arteries and slowly dissolves over time, releasing a drug to prevent re-blockage. The go…
Phase: NA • Sponsor: Biotyx Medical (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:12 UTC